Shuttle Pharmaceuticals Holdings SHPH
NASDAQ SHPH
$3.76 +0.05 (+1.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Shuttle Pharmaceuticals Holdings (SHPH) Long-Term Debt Repayments (2024)

Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Long-Term Debt Repayments of $345139.0 for Q3 2024.

Shuttle Pharmaceuticals Holdings (SHPH) Long-Term Debt Repayments (2024) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at $345139.0 for Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -156,847.56
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Shuttle Pharmaceuticals Holdings 1.93 Mn 1.93 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 345,139.00
Sep 30, 2024 345,139.00